Follow-The-Filings

AVIR · Atea Pharmaceuticals Inc.

Q1 2022 13F holders

← latest ownership dossier

Ticker
AVIR
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares